Celgene is one of the world's largest biotech companies, with annual sales of more than $5 billion. Its mission is to discover and develop treatments for cancer and other severe inflammatory conditions. To that end, Celgene’s most valuable asset is its intellectual property portfolio. Cozen O’Connor protects that portfolio by handling all of Celgene’s non-patent intellectual property work, including transactions, prosecutions, enforcement, and litigation.
READ FULL CLIENT STORY